The term 'Ozempic vulva' refers to sagging skin and other changes in the vulvar area reported by women using GLP-1 agonists like Ozempic for weight loss, likely due to rapid fat loss and muscle weakening. While some opt for non-invasive treatments like moisturizers or pelvic exercises, others consider procedures such as labia puffing or labiaplasty. More scientific research is needed to understand these effects fully.
'Ozempic vulva' refers to vaginal and vulvar changes such as sagging skin and dryness reported by women using GLP-1 drugs like Ozempic, primarily due to rapid weight loss leading to loss of fat pads and tissue support, rather than a direct side effect of the medication itself. Experts suggest these changes are reversible and related to body composition shifts, with management options including pelvic therapy and gradual weight loss.
A woman shares her experience of 'Ozempic vulva,' a term for vulvar sagging and other genital changes linked to rapid weight loss from drugs like Ozempic, highlighting that these effects are due to quick weight loss rather than the medication itself, and emphasizing the importance of medical supervision.
Women using Ozempic and similar GLP-1 medications have reported a rare side effect called 'Ozempic vulva,' characterized by sagging, muscle weakness, and dryness in the vulva and vagina, likely due to rapid weight loss and fat loss in the area. While not officially recognized, some are seeking treatments like dermal fillers or surgery, and users are advised to consult healthcare professionals for any concerns.
